SRF617

· Coherus Oncology, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SRF617, covering 2024-05-17 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of SRF617 in Patients With Advanced Solid Tumors [Phase 1]